Archives: Agenda

Navigating data consent in the digital era: innovations in clinical, healthcare, and big data technologies

  • Understanding data consent: exploring the importance and challenges of obtaining (informed) consent in the context of modern clinical and tion: examining how digital advancements and big data technologies impact data consent processes in healthcare and clinical settings, and how AI tools can enhance consent procedures for improving patient control of their data and data privacy
  • Regulatory and ethical considerations: discussing the evolving regulatory landscape and ethical considerations surrounding data consent in the era of digital health and big data, including the use of synthetic healthcare data to address privacy concerns.

INTERACTIVE PANEL DISCUSSION: Exploring the emerging dynamic capabilities of real-world data in clinical trials to enable safer decision-making in the drug development pipeline

  • Discovering innovative, digital protocols that adapt based on real-world insights, fostering agility in study design and conduct
  • Recognising the importance of collaboration among all trial stakeholders to achieve secure access to vital RWD and maximize its true value
  • From a data management standpoint, how to ensure data traceability and integrity?
  • Promising consistency in larger data sets and compliance when handling multiple sources of data

INTERACTIVE PANEL DISCUSSION: Driving scalable innovation that will shape the future of clinical research: The latest technologies that should be on your radar

  • Assessing the value of innovation in clinical trials: sharing best practice on engaging sites with new technology
  • Training sites and staff on new systems to maximize the benefits, streamline processes and enhance patient experience
  • Selecting the right technology vendors for data collection and analysis
  • Can synthetic data succeed in overcoming data limitations?